We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 494 results
  1. ALDH1A1 promotes PARP inhibitor resistance by enhancing retinoic acid receptor-mediated DNA polymerase θ expression

    Poly (ADP-ribose) Polymerase (PARP) inhibitors (PARPi) have been approved for both frontline and recurrent setting in ovarian cancer with homologous...

    Kousalya Lavudi, Ananya Banerjee, ... Qi-En Wang in npj Precision Oncology
    Article Open access 10 July 2023
  2. Autism patient-derived SHANK2BY29X mutation affects the development of ALDH1A1 negative dopamine neuron

    Autism spectrum disorder (ASD) encompasses a range of neurodevelopmental conditions. Different mutations on a single ASD gene contribute to...

    Wan**g Lai, Yingying Zhao, ... Lingling Shi in Molecular Psychiatry
    Article Open access 04 May 2024
  3. An antisense Alu transposon insertion/deletion polymorphism of ALDH1A1 may functionally associate with Parkinson’s disease

    Background

    Aldehyde dehydrogenase 1 (encoded by ALDH1A1 ) has been shown to protect against Parkinson’s disease (PD) by reducing toxic metabolites of...

    Hui-Hui Fan, **g Zheng, ... Jian-Hong Zhu in BMC Geriatrics
    Article Open access 16 May 2022
  4. Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis

    Cyclophosphamide (CP), an important alkylating agent which is used in the treatment therapy for chronic myeloid leukemia (CML). However, acquired...

    Gera Narendra, Baddipadige Raju, ... Om Silakari in Medical Oncology
    Article 07 September 2021
  5. Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma

    Background

    Spalt-like transcription factor 4 (SALL4) and aldehyde dehydrogenase1 family member A1 (ALDH1A1) expressing cells have been characterized...

    Mina Sharbatoghli, Parisa Shamshiripour, ... Leili Saeednejad Zanjani in Journal of Ovarian Research
    Article Open access 28 January 2022
  6. Investigation of an ALDH1A1-specific inhibitor for suppression of weight gain in a diet-induced mouse model of obesity

    Background

    Retinoic acid (RA) controls diverse physiological functions including weight regulation and energy metabolism. It has been reported that...

    Michael Haenisch, Tai Nguyen, ... Jisun Paik in International Journal of Obesity
    Article 01 May 2021
  7. Cancer Stem Cells of Esophageal Adenocarcinoma are Suppressed by Inhibitors of TRPV2 and SLC12A2

    Background

    The potential of membrane transporters activated in cancer stem cells (CSCs) as new therapeutic targets for cancer is attracting increasing...

    Atsushi Shiozaki, Hiroyuki Inoue, ... Eigo Otsuji in Annals of Surgical Oncology
    Article 08 September 2023
  8. RNA-sequencing predicts a role of androgen receptor and aldehyde dehydrogenase 1A1 in osteosarcoma lung metastases

    One-third of pediatric patients with osteosarcoma (OS) develop lung metastases (LM), which is the primary predictor of mortality. While current...

    Tanya E. Heim, Margaret L. Hankins, ... Rebecca J. Watters in Oncogene
    Article Open access 15 February 2024
  9. Establishment and analysis of a novel diagnostic model for systemic juvenile idiopathic arthritis based on machine learning

    Background

    Systemic juvenile idiopathic arthritis (SJIA) is a form of childhood arthritis with clinical features such as fever, lymphadenopathy,...

    Pan Ding, Yi Du, ... Li Huang in Pediatric Rheumatology
    Article Open access 19 January 2024
  10. Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating NBL1 and activating the BMP2/Smad/ID1 pathway

    Little is known about the biological functions of neuron-specific enolase (NSE) as a specific biomarker for small-cell lung cancer (SCLC). Herein, we...

    Lin Lu, Zhiqiang Zha, ... Guolong Liu in Oncogenesis
    Article Open access 29 April 2022
  11. Lack of association of CYP2B6 pharmacogenetics with cyclophosphamide toxicity in patients with cancer

    Purpose

    Cyclophosphamide is a commonly used cancer agent that is metabolically activated by polymorphic enzymes. This study aims to investigate the...

    Mary Hwang, Sarah Medley, ... Daniel L. Hertz in Supportive Care in Cancer
    Article 24 May 2022
  12. Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson’s disease

    We performed transcriptome analysis using RNA sequencing on substantia nigra pars compacta (SNpc) from mice after acute and chronic...

    Aditi Verma, Reddy Peera Kommaddi, ... Vijayalakshmi Ravindranath in Journal of Neural Transmission
    Article 23 February 2023
  13. Identification of an ADME-related gene for forecasting the prognosis and responding to immunotherapy in sarcomas

    There are more than 170 subtypes of sarcomas (SARC), which pose a challenge for diagnosis and patient management. Relatively simple or complex...

    Jianlong Wang, Guowei Wang, ... Yong Zhou in European Journal of Medical Research
    Article Open access 11 January 2024
  14. RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1

    Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an oncofetal protein expressed in various cancers including leukemia. In this study,...

    Irina A. Elcheva, Tyler Wood, ... Vladimir S. Spiegelman in Leukemia
    Article 25 November 2019
  15. Wt1 haploinsufficiency induces browning of epididymal fat and alleviates metabolic dysfunction in mice on high-fat diet

    Aims/hypothesis

    Despite a similar fat storing function, visceral (intra-abdominal) white adipose tissue (WAT) is detrimental, whereas subcutaneous WAT...

    Karin M. Kirschner, Anna Foryst-Ludwig, ... Holger Scholz in Diabetologia
    Article Open access 30 November 2021
  16. A sporadic Parkinson’s disease model via silencing of the ubiquitin–proteasome/E3 ligase component, SKP1A

    Our and other’s laboratory microarray-derived transcriptomic studies in human PD substantia nigra pars compacta (SNpc) samples have opened an avenue...

    Tali Fishman-Jacob, Moussa B. H. Youdim in Journal of Neural Transmission
    Article Open access 29 August 2023
  17. Creation of a gene expression classifier for predicting Parkinson’s disease rate of progression

    Parkinson’s disease (PD) etiology is heterogeneous, genetic, and multi-factorial, resulting in a varied disease from a mild slow progression to a...

    Jose Martin Rabey, Jennifer Yarden, ... Moussa B. H. Youdim in Journal of Neural Transmission
    Article 08 May 2020
  18. Generation of human A9 dopaminergic pacemakers from induced pluripotent stem cells

    The degeneration of nigral (A9) dopaminergic (DA) neurons causes motor symptoms in Parkinson’s disease (PD). We use small-molecule compounds to...

    Hong Li, Houbo Jiang, ... Jian Feng in Molecular Psychiatry
    Article 24 May 2022
  19. Bioinformatics integrated analysis to investigate candidate biomarkers and associated metabolites in osteosarcoma

    Background

    This study hoped to explore the potential biomarkers and associated metabolites during osteosarcoma (OS) progression based on...

    Jun Wang, Mingzhi Gong, ... Deguo **ng in Journal of Orthopaedic Surgery and Research
    Article Open access 05 July 2021
  20. Use of nCounter mRNA profiling to identify at-arrival gene expression patterns for predicting bovine respiratory disease in beef cattle

    Background

    Transcriptomics has identified at-arrival differentially expressed genes associated with bovine respiratory disease (BRD) development;...

    Matthew A. Scott, Amelia R. Woolums, ... Dan R. Goehl in BMC Veterinary Research
    Article Open access 23 February 2022
Did you find what you were looking for? Share feedback.